CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Acute myeloid leukemia (AML) is the second most common type of leukemia diagnosed in adults and children ...
Phase 1
Austin, Texas, United States and 23 other locations
The purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) and/or recommended dose (RD) of SG...
Phase 1
Austin, Texas, United States and 11 other locations
(mCRPC), higher risk myelodysplastic syndrome (HRMDS), acute myeloid leukemia (AML) and newly diagnosed intermed...
Phase 1, Phase 2
Austin, Texas, United States and 45 other locations
This study is a first-in-human, Phase 1a/1b, multicenter, open-label study to determine the safety, tolerability, and pharmacokinetics of aplitabart...
Phase 1
Austin, Texas, United States and 57 other locations
This Phase 1 study will assess the safety, tolerability, and preliminary antileukemic activity of ziftomenib in combination with venetoclax and azaci...
Phase 1
Austin, Texas, United States and 27 other locations
Some people with MDS have a risk of the disease progressing to acute myeloid leukemia (AML), and a risk of death ...
Phase 3
Austin, Texas, United States and 221 other locations
with bone marrow from a deceased donor in patients with acute leukemias. Patients will either receive myeloablative conditioning or...
Phase 1, Phase 2
Austin, Texas, United States and 3 other locations
azacitidine. (An event is defined as death or transformation to AML in participants with MDS or CMML, whichever occurs first, and is defined...
Phase 3
Austin, Texas, United States and 240 other locations
Clinical trials
Research sites
Resources
Legal